ClinicalTrialsFinder

Cancers Which Are CD44v6 Positive Clinical Trials in Shenzhen, Guangdong

1 recruitingShenzhen, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

4SCAR-CD44v6 T Cell Therapy Targeting Cancer

Cancers Which Are CD44v6 Positive
Shenzhen Geno-Immune Medical Institute100 enrolled3 locationsNCT04427449